Cashu | Summary

DJI

+1.36%

SPX

+0.85%

IXIC

+0.72%

FTSE

+0.78%

N225

+1.22%

AXJO

0.00%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

+1.36%

SPX

+0.85%

IXIC

+0.72%

FTSE

+0.78%

N225

+1.22%

AXJO

0.00%

HomeWatchlistNewsSignalsPicks

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap

4.44B

Dividend Yield

0.00%

P/E Ratio

12.74

EPS

2.23

Revenue

1.56B

Avg. Volume

3.27M

Stocks

Health Care

alks

Alkermes plc

NASDAQ: ALKS

+0.78 (+2.90%)

27.71

USD

At close at Sep 11, 20:08 UTC

About

What does ALKS do?

Alkermes Plc is a biopharmaceutical company based in Dublin, focused on developing treatments for alcohol and opioid dependence, schizophrenia, and bipolar I disorder, employing 2,100 people. Its key products include LYBALVI, ARISTADA, and VIVITROL, with ongoing development for neurological disorders and cancer.

Sector

💻 Health Care

IPO

CEO

Employees

1,800

Headquarters

Ireland

Website

http://www.alkermes.com